[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Top Market Movers: Negative News Full Access: $BCAX 17.11$ -XXXX% October XX 2025 Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1124 followers, XXX engagements
"I found you a Golden Cross on the daily chart of Bicara Therapeutics Inc. Common Stock. A Golden Cross is just X indicator of the many. Read my full analysis of Bicara Therapeutics Inc. Common Stock here: Follow: #PenkeTrading_USA $bcax #Bicara #GoldenCross #NASDAQ"
X Link @PenkeTrading 2025-10-14T11:26Z 3822 followers, XXX engagements
"🚨 BTD Moonshot Two more Breakthrough Therapy Designations hit the tape: $ONC Sonrotoclax (BCL-2i MCL) $BCAX Ficerafusp (EGFR x TGF 1L HPV HNSCC) Both stocks popped but nowhere near the outsized reactions we saw last week. Heres why 👇🏼 1The Market Already Knew Investors had been expecting these BTDs. Both drugs showed strong early data and were in active FDA communication. When everyones positioned for good news even great news just confirms whats priced in. 2Risk Isnt Gone BTD lowers regulatory friction but doesnt remove clinical risk. Sonrotoclax still needs to differentiate from $AABV"
X Link @BowTiedBiotech 2025-10-14T10:49Z 21K followers, 6312 engagements
"📌 Biotech Stock News 10/13 @ Midday $CGEN XX% COM701 Pooled Analysis $RCUS X% Median OS Data in Ph2 Study $ANAB X% Late-Breaking Presentation at ACR $BCAX X% Ficerafusp Alfa Granted Breakthrough Designation $MNKD X% FDA Review for Inhaled Insulin in Youth $ADGM X% Preliminary Acute Results from FULCRUM-VT $ONC X% Sonrotoclax Breakthrough Therapy Designation $CGEM X% Present Zipalertinib Data at ESMO $HCM X% FRUSICA-2 Registration Trial Data at ESMO $NTRA X% IMvigor011 Oral Presentation at ESMO $APGE X% Closed $345M Public Offering $MRNA X% Cancer Antigen Therapy Data at ESMO $EVAX X% EVX-01"
X Link @BiopharmIQ 2025-10-13T16:58Z 27.4K followers, 9213 engagements